Cited by 425Marine Sponges and Natural ProductsMicrobial Natural Products and BiosynthesisSynthesis and Biological Activity

Marine natural products and their potential applications as anti-infective agents

Open access
Donia, Marwa, Hamann, Mark T·2003·The Lancet Infectious Diseases

Abstract

The oceans are a unique resource that provide a diverse array of natural products, primarily from invertebrates such as sponges, tunicates, bryozoans, and molluscs, and from marine bacteria and cyanobacteria. As infectious diseases evolve and develop resistance to existing pharmaceuticals, the marine environment provides novel leads against fungal, parasitic, bacterial, and viral diseases. Many marine natural products have successfully advanced to the late stages of clinical trials, including dolastatin 10, ecteinascidin-743, kahalalide F, and aplidine, and a growing number of candidates have been selected as promising leads for extended preclinical assessment. Although many marine-product clinical trials are for cancer chemotherapy, drug resistance, emerging infectious diseases, and the threat of bioterrorism have all contributed to the interest in assessing natural ocean products in the treatment of infectious organisms. In this review, we focus on the pharmacologically tested marine leads that have shown in-vivo efficacy or potent in-vitro activity against infectious and parasitic diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(03)00655-8

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Donia, M., & Hamann, M. T.
Affiliations
University of Mississippi (US)
Corresponding author
Hamann, Mark T
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2003-06
Volume
3
Issue
6
Pages
338-348
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2165757703
Cited by
425
References
79
Citations by year
2026: 7 · 2025: 13 · 2024: 25 · 2023: 21 · 2022: 19 · 2021: 20 · 2020: 24 · 2019: 14 · 2018: 20 · 2017: 17 · 2016: 22 · 2015: 26 · 2014: 22 · 2013: 24 · 2012: 32
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (K02AI001502, R01AI036596, KO2AI01502, R01 AI 36596)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
  • Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Synthesis and Biological Activity
Keywords
marine natural products, anti-infective agents, marine sponges, tunicates, Bryozoa, marine bacteria, marine cyanobacteria, antifungal agents, antiparasitic drugs, antibacterial agents, antiviral agents, drug resistance, emerging infectious diseases, dolastatin 10, trabectedin, kahalalide F, marine-derived drugs
MeSH terms
Animals, Anthelmintics, Anti-Bacterial Agents, Antifungal Agents, Antiprotozoal Agents, Antitubercular Agents, Antiviral Agents, Humans, Invertebrates, Marine Biology, Phytotherapy, Drugs, Investigational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review